Standout Papers

Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, ... 2022 2026 2023 2024144
  1. Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India (2022)
    Shrikant Deshpande, Krishna Giri et al. The Lancet

Immediate Impact

30 standout
Sub-graph 1 of 12

Citing Papers

Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
Systematic and comprehensive insights into HIF-1 stabilization under normoxic conditions: implications for cellular adaptation and therapeutic strategies in cancer
2025 Standout
2 intermediate papers

Works of Parshottam Koradia being referenced

Desidustat in Anemia due to Non-Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-ND)
2022
Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India
2022 Standout

Author Peers

Author Last Decade Papers Cites
Parshottam Koradia 161 47 9 75 57 5 265
Paige M Mortimer 181 58 6 60 63 7 326
Federica Di Timoteo 157 34 69 20 6 298
Ikbel Hadj Hassine 203 39 1 70 38 7 292
Hsin‐Che Huang 95 24 19 210 96 11 328
Han-Sol Park 63 115 1 55 60 8 305
Adnan Mushtaq 168 86 28 24 7 275
Shi Yin Wong 251 23 17 41 6 300
Stefanie Marx 247 37 57 60 12 325
Mohamed Yaseen Alsabbagh 136 34 38 81 6 273
Tatiana Roy 212 11 18 35 33 7 259

All Works

Loading papers...

Rankless by CCL
2026